1
2
le Yuan, Dumin, Ma, Zhiyuan, Tuo, Biguang, Li, Taolang, Liu, Xuemei
Foilsithe in Evid Based Complement Alternat Med (2020)
Faigh an téacs iomlánFoilsithe in Evid Based Complement Alternat Med (2020)
Faigh an téacs iomlán
Faigh an téacs iomlán
Artigo
3
4
le Wang, Hu, Ma, Zhiyuan, Cheng, Xiaoming, Tuo, Biguang, Liu, Xuemei, Li, Taolang
Foilsithe in Onco Targets Ther (2020)
Faigh an téacs iomlánFoilsithe in Onco Targets Ther (2020)
Faigh an téacs iomlán
Faigh an téacs iomlán
Artigo
5
le Lu, Chengli, Ma, Zhiyuan, Cheng, Xiaoming, Wu, Huichao, Tuo, Biguang, Liu, Xuemei, Li, Taolang
Foilsithe in Cancer Cell Int (2020)
Faigh an téacs iomlánFoilsithe in Cancer Cell Int (2020)
Faigh an téacs iomlán
Faigh an téacs iomlán
Artigo
6
le Zeng, Feng, Huang, Liangliang, Cheng, Xiaoming, Yang, Xiaoli, Li, Taolang, Feng, Guoli, Tang, Yingqi, Yang, Yan
Foilsithe in Cancer Cell Int (2018)
Faigh an téacs iomlánFoilsithe in Cancer Cell Int (2018)
Faigh an téacs iomlán
Faigh an téacs iomlán
Artigo
7
8
le Yu, Qin, Liu, Xuemei, Liu, Yongjian, Riederer, Brigitte, Li, Taolang, Tian, De-An, Tuo, Biguang, Shull, Gary, Seidler, Ursula
Foilsithe in Pflugers Arch (2016)
Faigh an téacs iomlánFoilsithe in Pflugers Arch (2016)
Faigh an téacs iomlán
Faigh an téacs iomlán
Artigo
9
le Li, Taolang, Ma, Zhiyuan, Lu, Chengli, Zhou, Quanzhong, Feng, Zelong, Wu, Xinglong, Luo, Yi, Li, Dan, Cheng, Xiaoming, Liu, Xuemei
Foilsithe in Diagn Pathol (2019)
Faigh an téacs iomlánFoilsithe in Diagn Pathol (2019)
Faigh an téacs iomlán
Faigh an téacs iomlán
Artigo